Citation Impact

Citing Papers

Human cerebral organoids recapitulate gene expression programs of fetal neocortex development
2015 StandoutNobel
Nuclear Janus-Activated Kinase 2/Nuclear Factor 1-C2 Suppresses Tumorigenesis and Epithelial-to-Mesenchymal Transition by Repressing Forkhead Box F1
2010
Loss of NFIX Transcription Factor Biases Postnatal Neural Stem/Progenitor Cells Toward Oligodendrogenesis
2015
Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor–Positive Advanced Breast Cancer
2018
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
The Tumor Suppressor Protein p53 Requires a Cofactor to Activate Transcriptionally the Human BAX Promoter
2001
Vaccines against dengue: a review of current candidate vaccines at advanced development stages
2007
Evolution of Papillomaviruses
1994
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
Mechanisms Identified in the Transcriptional Control of Epithelial Gene Expression
1996
The history of cancer epigenetics
2004 Standout
Mechanism and medical implications of mammalian autophagy
2018 Standout
Modulation of human α1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitro
1998
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Papillomavirus infections — a major cause of human cancers
1996 StandoutNobel
Classification of papillomaviruses
2004 StandoutNobel
ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules
2016 Standout
Juvenile idiopathic arthritis
2007 Standout
Analysis of the E-cadherin and P-cadherin promoters in murine keratinocyte cell lines from different stages of mouse skin carcinogenesis
1997
The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression
2000 Standout
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
2000 Standout
α(1,3)Fucosyltransferases Expressed by the Gain-of-Function Chinese Hamster Ovary Glycosylation Mutants LEC12, LEC29, and LEC30
2000
The Sp-family of transcription factors
1999
The molecular biology of head and neck cancer
2010 Standout
Organization of the α-Globin Promoter and Possible Role of Nuclear Factor I in an α-Globin-inducible and in a Noninducible Cell Line
1995
Sp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancer
2001
A tale of three fingers: the family of mammalian Sp/XKLF transcription factors
1999
IL-6 as a keystone cytokine in health and disease
2015 Standout
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.
1998 Standout
SUMO
2005 Standout
Expression of AP1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells.
1997
Dengue: a continuing global threat
2010 Standout
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
2022 StandoutNobel
The epithelial cell default‐phenotype hypothesis and its implications for cancer
1997
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Alternative dosage schedules with HPV virus-like particle vaccines
2014
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
p21 in cancer: intricate networks and multiple activities
2009 Standout
The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation
2002 Standout
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
2000 Standout
Transglutaminases: crosslinking enzymes with pleiotropic functions
2003 Standout
Differential expression and activation of NF‐κB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection
2006
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Deconvolution of Buparlisib’s mechanism of action defines specific PI3K and tubulin inhibitors for therapeutic intervention
2017
The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells
2000 Standout
Dengue
2012 Standout
Regulation of the Transglutaminase I Gene
1999
B cell–specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers
2009 StandoutNobel
Cellular control of human papillomavirus oncogene transcription
1994
Expression of multiple classes of the Nuclear Factor-1 family in the developing human brain: Differential expression of two classes of NF-1 genes
1996
SUMO-1 Modification Represses Sp3 Transcriptional Activation and Modulates Its Subnuclear Localization
2002
Autophagy: controlling cell fate in rheumatic diseases
2016
The PI3K Pathway in Human Disease
2017 Standout
Dengue Vaccine Candidates in Development
2009
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Genetic complementation to non-tumorigenicity in cervical-carcinoma cells correlates with alterations in AP-1 composition
2000 StandoutNobel
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Human Papillomaviruses and cervical Cancer
1997
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
2004 Standout
Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex
1999 StandoutNobel
Laboratory-Directed Protein Evolution
2005
A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoter
1995 StandoutNobel
Utility of Humanized BLT Mice for Analysis of Dengue Virus Infection and Antiviral Drug Testing
2013 StandoutNobel
Histone deacetylases (HDACs): characterization of the classical HDAC family
2003 Standout
Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro
2012 StandoutNobel
Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region
1993
Neuronal Expression of the 5HT3Serotonin Receptor Gene Requires Nuclear Factor 1 Complexes
1998 StandoutNobel
Felis domesticus papillomavirus, isolated from a skin lesion, is related to canine oral papillomavirus and contains a 1·3 kb non-coding region between the E2 and L2 open reading frames
2002
The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1.
1994
Transcriptional control of human p53-regulated genes
2008 Standout
Human Papillomavirus and Cervical Cancer
2003 Standout
Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16.
1999
Disturbance of Tumor Necrosis Factor Alpha-Mediated Beta Interferon Signaling in Cervical Carcinoma Cells
2002 StandoutNobel
Transcriptional Control and Cell Type Specificity of HPV Gene Expression
1994
Characterization of a novel genital human papillomavirus by overlapping PCR: candHPV86 identified in cervicovaginal cells of a woman with cervical neoplasia
2001
Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world
1995
Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription
1997 StandoutNobel
Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri.
1996
Steering directed protein evolution: strategies to manage combinatorial complexity of mutant libraries
2007
Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes
1997
Deletion of the C-Terminal Region of Dengue Virus Nonstructural Protein 1 (NS1) Abolishes Anti-NS1-Mediated Platelet Dysfunction and Bleeding Tendency
2009
Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells.
1992 StandoutNobel
Regulation of human papillomavirus transcription by the differentiation-dependent epithelial factor Epoc-1/skn-1a
1996
Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids
1994 StandoutNobel
Protein Modification by SUMO
2004 Standout
Directed Evolution ofVibrio fischeriLuxR for Improved Response to Butanoyl-Homoserine Lactone
2007 StandoutNobel
Mutational analyses of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytes.
1997
Chemical and Biological Strategies for Engineering Cell Surface Glycosylation
2001 StandoutNobel
Adeno-Associated Virus Major Rep78 Protein Disrupts Binding of TATA-Binding Protein to the p97 Promoter of Human Papillomavirus Type 16
2000
CpG Methylation of Human Papillomavirus Type 16 DNA in Cervical Cancer Cell Lines and in Clinical Specimens: Genomic Hypomethylation Correlates with Carcinogenic Progression
2003

Works of Doris Apt being referenced

Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors
2016
NFI-B3, a Novel Transcriptional Repressor of the Nuclear Factor I Family, Is Generated by Alternative RNA Processing
1997
High Sp1/Sp3 Ratios in Epithelial Cells during Epithelial Differentiation and Cellular Transformation Correlate with the Activation of the HPV-16 Promoter
1996
Cloning and functional analysis of spliced isoforms of human nuclear factor I-X: interference with transcriptional activation by NFI/CTF in a cell-type specific manner
1994
Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen
2005
Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, placebo-controlled, phase II randomised PEGGY study
2016
Overcoming antigenic diversity and improving vaccines using DNA shuffling and screening technologies
2004
Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16
1993
The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription
1991
A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques
2006
Endogenous retroviral env genes after N-methyl-N'-nitro-N-nitrosoguanidine treatment of mouse tumor cells: stable DNA amplification and rearrangement.
1989
Rankless by CCL
2026